InvestorsObserver
×
News Home

Where Does CorMedix Inc. (CRMD) Stock Fall in the Biotechnology Field After It Has Risen 12.85% This Week?

Monday, November 06, 2023 10:59 AM | InvestorsObserver Analysts

Mentioned in this article

Where Does CorMedix Inc. (CRMD) Stock Fall in the Biotechnology Field After It Has Risen 12.85% This Week?

CorMedix Inc. (CRMD) is near the top in its industry group according to InvestorsObserver. CRMD gets an overall rating of 62. That means it scores higher than 62 percent of stocks. CorMedix Inc. gets a 80 rank in the Biotechnology industry. Biotechnology is number 46 out of 148 industries.

Overall Score - 62
CRMD has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on CRMD!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With CorMedix Inc. Stock Today?

CorMedix Inc. (CRMD) stock is trading at $3.60 as of 10:40 AM on Monday, Nov 6, an increase of $0.11, or 3.15% from the previous closing price of $3.49. The stock has traded between $3.49 and $3.62 so far today. Volume today is less active than usual. So far 133,419 shares have traded compared to average volume of 448,966 shares. Click Here to get the full Stock Report for CorMedix Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App